Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

about

c-Kit (CD117) expression in classic Kaposi's sarcoma.(A1) Identification of oral health care needs in children and adults, management of oral diseases.

P2860

Q43252684-3F96A325-2570-4026-B2D7-D8970B06C4AB Q44799270-3FD07AC7-D701-4662-887F-659C013397AB

P2860

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

Item

http://www.wikidata.org/entity/Q35779249

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

@ast

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

@en

type

Item

label

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

@ast

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

@en

prefLabel

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

@ast

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

@en

P1476

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

@en

P2093

Anna Maria Cattelan

http://www.w3.org/2001/XMLSchema#string

Marco Trevenzoli

http://www.w3.org/2001/XMLSchema#string

Savina Maria Lucia Aversa

http://www.w3.org/2001/XMLSchema#string

P2860

Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone

Thalidomide is an inhibitor of angiogenesis

The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: a pilot clinical study.

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome.

Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.

Antiproliferative effect of retinoid compounds on Kaposi's sarcoma cells

Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma.

Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.

P304

501-513

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.13.5.501

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15155125

http://www.w3.org/2001/XMLSchema#string

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

about

P2860

P2860

Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698